210 related articles for article (PubMed ID: 7700647)
21. [Analysis of the p53 gene status of lymph node metastasis in the head and neck region in occult primary cancer].
Gottschlich S; Schuhmacher O; Görögh T; Hoffmann M; Maune S
Laryngorhinootologie; 2000 Jul; 79(7):434-7. PubMed ID: 11005098
[TBL] [Abstract][Full Text] [Related]
22. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
[TBL] [Abstract][Full Text] [Related]
23. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
[TBL] [Abstract][Full Text] [Related]
24. The incidence of p53 mutations increases with progression of head and neck cancer.
Boyle JO; Hakim J; Koch W; van der Riet P; Hruban RH; Roa RA; Correo R; Eby YJ; Ruppert JM; Sidransky D
Cancer Res; 1993 Oct; 53(19):4477-80. PubMed ID: 8402617
[TBL] [Abstract][Full Text] [Related]
25. TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe.
Tanière P; Martel-Planche G; Saurin JC; Lombard-Bohas C; Berger F; Scoazec JY; Hainaut P
Br J Cancer; 2001 Sep; 85(5):721-6. PubMed ID: 11531258
[TBL] [Abstract][Full Text] [Related]
26. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients.
Kropveld A; van Mansfeld AD; Nabben N; Hordijk GJ; Slootweg PJ
Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):388-93. PubMed ID: 9039222
[TBL] [Abstract][Full Text] [Related]
27. Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community.
Oliva MR; Ripoll F; Muñiz P; Iradi A; Trullenque R; Valls V; Drehmer E; Sáez GT
Mol Carcinog; 1997 Apr; 18(4):232-43. PubMed ID: 9142218
[TBL] [Abstract][Full Text] [Related]
28. High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas.
Valentin-Vega YA; Barboza JA; Chau GP; El-Naggar AK; Lozano G
Hum Pathol; 2007 Oct; 38(10):1553-62. PubMed ID: 17651783
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of the p53 gene in primary and metastatic head and neck carcinomas.
Sauter ER; Ridge JA; Trock B; Cleveland D; Whitley KV; Mohr RM; Klein-Szanto A
Laryngoscope; 1995 Jun; 105(6):653-6. PubMed ID: 7769953
[TBL] [Abstract][Full Text] [Related]
30. A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinoma.
Gorgoulis VG; Zoumpourlis V; Rassidakis GZ; Karameris A; Rassidakis AN; Spandidos DA; Kittas C
J Pathol; 1996 Oct; 180(2):129-37. PubMed ID: 8976869
[TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
[TBL] [Abstract][Full Text] [Related]
32. Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance.
Millon R; Muller D; Schultz I; Salvi R; Ghnassia JP; Frebourg T; Wasylyk B; Abecassis J
Oral Oncol; 2001 Dec; 37(8):620-31. PubMed ID: 11590071
[TBL] [Abstract][Full Text] [Related]
33. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
34. The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
Götte K; Riedel F; Neubauer J; Schäfer C; Coy JF; Hörmann K
Int J Oncol; 2001 Aug; 19(2):331-6. PubMed ID: 11445847
[TBL] [Abstract][Full Text] [Related]
35. Altered patterns of MDM2 and TP53 expression in human bladder cancer.
Lianes P; Orlow I; Zhang ZF; Oliva MR; Sarkis AS; Reuter VE; Cordon-Cardo C
J Natl Cancer Inst; 1994 Sep; 86(17):1325-30. PubMed ID: 8064890
[TBL] [Abstract][Full Text] [Related]
36. p53, retinoblastoma, and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract.
Lee NK; Ye YW; Chen J; Li X; Waber PG; Nisen PD
Arch Otolaryngol Head Neck Surg; 1993 Oct; 119(10):1125-31. PubMed ID: 8398064
[TBL] [Abstract][Full Text] [Related]
37. TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in south Thailand.
Tanière P; Martel-Planche G; Puttawibul P; Casson A; Montesano R; Chanvitan A; Hainaut P
Int J Cancer; 2000 Oct; 88(2):223-7. PubMed ID: 11004672
[TBL] [Abstract][Full Text] [Related]
38. TP53 genetic alterations in head-and-neck carcinomas from Brazil.
Nagai MA; Miracca EC; Yamamoto L; Moura RP; Simpson AJ; Kowalski LP; Brentani RR
Int J Cancer; 1998 Mar; 76(1):13-8. PubMed ID: 9533755
[TBL] [Abstract][Full Text] [Related]
39. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.
Brennan JA; Boyle JO; Koch WM; Goodman SN; Hruban RH; Eby YJ; Couch MJ; Forastiere AA; Sidransky D
N Engl J Med; 1995 Mar; 332(11):712-7. PubMed ID: 7854378
[TBL] [Abstract][Full Text] [Related]
40. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
Shin DM; Charuruks N; Lippman SM; Lee JJ; Ro JY; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):603-9. PubMed ID: 11401909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
